Search hospitals > Florida > Hialeah

Galiz Research

Claim this profile
Hialeah, Florida 33016
Global Leader in Alzheimer's Disease
Conducts research for Schizophrenia
Conducts research for Obsessive-Compulsive Disorder
Conducts research for Major Depressive Disorder
Conducts research for Depression
39 reported clinical trials
1 medical researcher
Photo of Galiz Research in HialeahPhoto of Galiz Research in HialeahPhoto of Galiz Research in Hialeah

Summary

Galiz Research is a medical facility located in Hialeah, Florida. This center is recognized for care of Alzheimer's Disease, Schizophrenia, Obsessive-Compulsive Disorder, Major Depressive Disorder, Depression and other specialties. Galiz Research is involved with conducting 39 clinical trials across 37 conditions. There are 1 research doctors associated with this hospital, such as Jose Gamez.

Area of expertise

1Alzheimer's Disease
Global Leader
Galiz Research has run 17 trials for Alzheimer's Disease. Some of their research focus areas include:
Aβ1-42 positive
Aβ1-42/Aβ1-40 ratio positive
ApoE
2Schizophrenia
Galiz Research has run 8 trials for Schizophrenia.

Top PIs

Clinical Trials running at Galiz Research

Depression
Systemic Mastocytosis
Major Depressive Disorder
Alzheimer's Disease
Schizophrenia
Leukemia
Dementia
Psychomotor Agitation
Agitation in Dementia
Anhedonia
Image of trial facility.

Aticaprant

for Depression

This trial is testing if adding aticaprant to current antidepressants is safe and well-tolerated in people with major depressive disorder. The goal is to see if it can help improve their treatment.
Recruiting2 awards Phase 316 criteria
Image of trial facility.

Aticaprant

for Major Depressive Disorder

This trial is testing aticaprant to see if it can help people with major depressive disorder who still feel very down and don't enjoy things despite taking other antidepressants. The study focuses on adults who haven't responded well to their current treatments. Aticaprant works by blocking a specific brain receptor, which might help improve their mood and reduce depressive symptoms.
Recruiting1 award Phase 36 criteria
Image of trial facility.

BI 1569912

for Depression

This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did not work. The purpose of the study is to find out whether a medicine called BI 1569912 helps people with depression. Participants continue their standard therapy throughout the study. Participants are put into 4 groups by chance. 3 of the 4 groups take different doses of BI 1569912. 1 group takes placebo. Placebo tablets looks like BI 1569912 but do not contain any medicine. Participants take the tablets once a day for 6 weeks. Participants are in the study for about 2 to 4 and a half months. During this time, they visit the study site at least 6 times. At the visits, doctors ask participants about their symptoms. The participants answer questions about their depression symptoms. The results are compared between the groups. The doctors also regularly check the general health of participants.
Recruiting0 awards Phase 23 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Galiz Research?
Galiz Research is a medical facility located in Hialeah, Florida. This center is recognized for care of Alzheimer's Disease, Schizophrenia, Obsessive-Compulsive Disorder, Major Depressive Disorder, Depression and other specialties. Galiz Research is involved with conducting 39 clinical trials across 37 conditions. There are 1 research doctors associated with this hospital, such as Jose Gamez.